The Latest Breaking News from FDA

And this lawsuit faces many of the same administrative law hurdles as does AHM v. FDA.

The spray version of naloxone will be available for sale by late summer. Experts praised the move to make it more accessible amid the national opioid crisis but are concerned it may be too expensive for some people.

After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…

The decision could make the life-saving drug more accessible. Emergent BioSolutions, the drug company that produces Narcan, said it anticipates it will be on store shelves by late summer.

The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription

The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription

Scratch the surface of a Skittles and, wow, you will find so much more than a chewy fruit-flavored sugar bomb. The shiny candy is a bit like a Rorschach test; you see what you want to see in those rainbow-colored morsels.

The Food and Drug Administration (FDA) has warned parents to be alert after "many children" in the south were hospitalised after eating smuggled cannabis-infused cookies containing excessive levels of psychoactive tetrahydrocannabinol (THC).

Thanks to onerous regulations, life-saving drugs are more expensive and harder to get.